Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Showing 1–8 of 8 · Primary care systems
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue €649.2m (-0.8%); operating margin 4.7%; net income €9.4m.
Balance sheet figures not captured from release.
FY2025 revenue €1.21bn (+5.0%).
Revenue +5% (organic +5%). Profit figures not yet captured.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Parent UnitedHealth Group (UNH) group FY2025 revenue $447.57bn (+11.8%); operating margin 4.2%; net income $12.06bn.
Optum: revenue $270.6bn (+7%), earnings from operations $9.5bn.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Part of TELUS (T.TO).
Latest full-year results not yet captured by HSH.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.